Evidence map›Paper›PMID 31663854›Full record

ArticleeLife2019

A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency.

Xiao Min Zhang, Urielle François, Kätlin Silm, Maria Florencia Angelo, Maria Victoria Fernandez-Busch, Mona Maged, Christelle Martin, Véronique Bernard, Fabrice P Cordelières, Melissa Deshors and 7 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xiao Min ZhangInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Urielle François *Interdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Kätlin Silm *Neuroscience Paris Seine NPS, Université Pierre et Marie Curie INSERM U1130 CNRS UMR8246, Paris, France.
Maria Florencia AngeloInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Maria Victoria Fernandez-BuschInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Mona MagedInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Christelle MartinInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Véronique BernardNeuroscience Paris Seine NPS, Université Pierre et Marie Curie INSERM U1130 CNRS UMR8246, Paris, France.
Fabrice P CordelièresBordeaux Imaging Center, Université de Bordeaux, CNRS UMS 3420, INSERM US4, Bordeaux, France.ORCID 0000-0002-5383-5816
Melissa DeshorsInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Stéphanie PonsInstitut Pasteur, CNRS UMR 3571, Unité NISC, Paris, France.
Uwe MaskosInstitut Pasteur, CNRS UMR 3571, Unité NISC, Paris, France.
Alexis Pierre BemelmansCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Direction de laRecherche Fondamentale (DRF), Institut de Biologie François Jacob (IBFJ), MolecularImaging Research Center (MIRCen), Fontenay-aux-Roses, France.
Sonja M WojcikDepartment of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
Salah El MestikawyNeuroscience Paris Seine NPS, Université Pierre et Marie Curie INSERM U1130 CNRS UMR8246, Paris, France.
Yann HumeauInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.
Etienne HerzogInterdisciplinary Institute for Neuroscience, Université de Bordeaux, Bordeaux, France.ORCID 0000-0002-0058-6959

Funding

Agence Nationale de la Recherche ANR-10-IDEX-03-02 PEPS SV-PITAgence Nationale de la Recherche ANR-10-INBS-04Agence Nationale de la Recherche ANR-10-LABX-43 BRAINAgence Nationale de la Recherche ANR-12-JSV4-0005-01 VGLUT-IQAgence Nationale de la Recherche PSYVGLUT 09-MNPS-033European Commission Erasmus-Mundus European Neuroscience Campus ProgramFondation pour la Recherche Médicale FDT20120925288Fondation pour la Recherche Médicale ING20150532192
6 · The paper itself

Abstract

Glutamate secretion at excitatory synapses is tightly regulated to allow for the precise tuning of synaptic strength. Vesicular Glutamate Transporters (VGLUT) accumulate glutamate into synaptic vesicles (SV) and thereby regulate quantal size. Further, the number of release sites and the release probability of SVs maybe regulated by the organization of active-zone proteins and SV clusters. In the present work, we uncover a mechanism mediating an increased SV clustering through the interaction of VGLUT1 second proline-rich domain, endophilinA1 and intersectin1. This strengthening of SV clusters results in a combined reduction of axonal SV super-pool size and miniature excitatory events frequency. Our findings support a model in which clustered vesicles are held together through multiple weak interactions between Src homology three and proline-rich domains of synaptic proteins. In mammals, VGLUT1 gained a proline-rich sequence that recruits endophilinA1 and turns the transporter into a regulator of SV organization and spontaneous release.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBiological TransportGlutamatesHumansMiceMice, KnockoutRatsSynaptic VesiclesVesicular Glutamate Transport Protein 1Adaptor Proteins, Signal TransducingGlutamatesSH3GL2 protein, humanVesicular Glutamate Transport Protein 1axoncell biologyliquid phase separationmouseneuroscienceneurotransmissionproline-rich domainsynaptic vesicle poolsVesicular Glutamate Transporter

Identifiers

PMID31663854
PMCPMC6861006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.